期刊
JOURNAL OF MOLECULAR STRUCTURE
卷 1241, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.molstruc.2021.130618
关键词
Alzheimer's disease; Acetylcholinesterase; MTDLs; Antioxidant; Molecular docking
资金
- research council of Oman (TRC) [FP/RGP/HSS/19/232/2019]
Alzheimer's disease is a major progressive cortical degenerative disease of the brain in the elderly, causing significant socioeconomic burden. A hybridized approach using multi-target directed ligands for developing therapeutic agents for AD has gained attention, with 20% of recent drug approvals following this strategy. The strategy of coupling coumarin scaffold with other bioactive pharmacophores has been highlighted as important for developing AD therapy.
Alzheimer's disease (AD) is a major progressive and perplexing cortical degenerative disease of the brain in the elderly. It contributes to a significant socioeconomic burden on patients, families, and care providers in comparison to cancer, cardiovascular diseases, and stroke in general. Recently, a hybridized approach based on multi-target directed ligands (MTDLs) has received considerable attention to develop therapeutic agents for AD which act at multiple targets. Approximately 20% of the drugs approved in the past couple of years were developed using the same strategy and thus it seems to be the right approach to develop AD therapy. The comprehensive and updated review on coumarin hybrids as MTDLs in AD therapy is compiled using several electronic databases such as Scopus, Google Scholar, SciFinder, Mendeley, and PubMed. The research studies published on coumarin hybrids in the last decade (2010-2020) have been covered in this review article. This updated review highlights the importance of coupling (hybridization) coumarin scaffold with other bioactive pharmacophores to develop MTDLs for AD therapy. It also covers the patents granted to coumarin derivatives for AD treatment, natural products containing coumarin scaffold with anti-Alzheimer spectrum, the rationale for coupling pharmacophore fragments, detailed structure activity relationship (SAR), and molecular docking studies. The most potent and promising hybrid compounds have also been identified for further development of AD drugs. Authors are of the opinion that hybridization strategy would soon yield drug candidates for the treatment of AD. (C) 2021 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据